Target Validation Information
TTD ID	T37539
Target Name	B-cell receptor CD22 (CD22)
Type of Target	Successful
Drug Potency against Target	Epratuzumab	Drug Info	Ki = 10 nM	[1]
References
REF 1	Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(6):R204.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.